PROJECTS
>>Ramp up of Product Development Efficiencies
>>Transformation through In-Licensing & Site Transfers
>>Out-License of New Molecular Entity by Biotech Footprint Late
>>Strengthening of Overseas Footprint
>>Divestment of Late Life Cycle Products
>>Commercializing a Reformulated Product
>>Business Development for Development Stage Enabling Technology
>>Restructuring Clinical Operations
>>Optimal Drug Development Path and Licensing Process
>>Post-Merger integration of Research and Development operations
Post-Merger integration of Research & Development operations
Our client, the Head of Development of a global pharmaceutical company in a post-merger situation, sought to build a world class development capability. Differences in legacy company cultures had to be overcome. Garphi and another associate were subsequently selected to assist in the change process. Using our associates’ change management methodology and the existing diagnostic to execute design, implementation and benefits realization phases, the project had complementary work streams to:
• Streamline development decision-making
• Establish effective teams for delivery of clinical development programs
• Optimize key clinical trial planning, and management processes
Garphi was successful in establishing new ways of working owned by the whole merged development organization, not linked to one legacy, but also ensure increased reliability of clinical development program timelines, cost reductions and resource optimization.
